Just after the deaths caused by the ciwujia herbal injection produced by Wandashan Pharmaceutical Company in China’s Heilongjiang Province, China’s Ministry of Health banned another herbal drug after it caused four newborns experiencing adverse reactions with one fatality.
According to Northeast.cn, the infants received an injection of Yinzhihuang, a drug used to treat liver diseases. One of the infants was only nine days old and died on October 11.
The report says that the Shanxi Province-based Taihang Pharmaceutical produced a total of 260,000 bottles of the Yinzhihuang injections under the batch number 071001, which were shipped to the provinces of Hebei, Shanxi, Jilin, Heilongjiang, Shandong, Yunnan and Shaanxi as well as the Ningxia Autonomous Region.
According to an October 20 Associated Press report, the Ministry of Health ordered hospitals across China to stop using Yinzhihuang. The producer, Taihang Pharmaceutical, said on its Web site Monday it recalled the flawed batch on Oct. 16, the day it learned of the baby’s death.
The Heilongjiang Provincial Health Department issued an urgent notice on Oct. 19 to request that all medical institutions in the province stop using the drug. The Department warned that these suspected injections should be taken off shelves, sealed, sent to both the health administration department and pharmaceutical supervisory for examination.
Friends Read Free
Copy
Facebook
Tweet
